A carregar...
FGFR Inhibitors in Oncology: Insight on the Management of Toxicities in Clinical Practice
SIMPLE SUMMARY: FGFR inhibitors evolved as therapeutic options in cholangiocarcinoma and urothelial malignancies. Given the implications of FGFR pathway in various physiological functions, FGFR inhibitors are known to cause unique toxicities. In this review, we summarized the physiology of FGF/FGFR...
Na minha lista:
| Publicado no: | Cancers (Basel) |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
MDPI
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8231807/ https://ncbi.nlm.nih.gov/pubmed/34199304 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13122968 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|